Targeting the Epidermal Growth Factor Receptor in Glioblastoma Treatment

By  

Current Signal Transduction Therapy, Vol. 7, Iss. 1, 2012-01 ,pp. : 3-13

Bentham Science Publishers

Access to resources Recommend Favorite

Dual blockade of epidermal growth factor receptor and insulin‐like growth factor receptor–1 signaling in metastatic pancreatic cancer: Phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727)

By  

CANCER, Vol. 120, Iss. 19, 2014-10 ,pp. : 2980-2985

John Wiley & Sons Inc

Access to resources Recommend Favorite

The proliferative effects of Pyropia yezoensis peptide on IEC-6 cells are mediated through the epidermal growth factor receptor signaling pathway

By            

International Journal of Molecular Medicine, Vol. 35, Iss. 4, 2015-01 ,pp. : 909-914

Spandidos Publications

Access to resources Recommend Favorite

FTY720 and cisplatin synergistically induce the death of cisplatin-resistant melanoma cells through the downregulation of the PI3K pathway and the decrease in epidermal growth factor receptor expression

By              

International Journal of Molecular Medicine, Vol. 34, Iss. 4, 2014-01 ,pp. : 1169-1174

Spandidos Publications

Access to resources Recommend Favorite

Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib

By  

CANCER, Vol. 121, Iss. 18, 2015-09 ,pp. : 3212-3220

John Wiley & Sons Inc

Access to resources Recommend Favorite